These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34689214)

  • 1. Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver.
    Prasad RB; Asplund O; Shukla SR; Wagh R; Kunte P; Bhat D; Parekh M; Shah M; Phatak S; Käräjämäki A; Datta A; Kakati S; Tuomi T; Saboo B; Ahlqvist E; Groop L; Yajnik CS
    Diabetologia; 2022 Jan; 65(1):65-78. PubMed ID: 34689214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic scores of diabetes-related traits in subgroups of type 2 diabetes in India: a cohort study.
    Yajnik CS; Wagh R; Kunte P; Asplund O; Ahlqvist E; Bhat D; Shukla SR; Prasad RB
    Lancet Reg Health Southeast Asia; 2023 Jul; 14():100182. PubMed ID: 37492423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.
    Zaharia OP; Strassburger K; Strom A; Bönhof GJ; Karusheva Y; Antoniou S; Bódis K; Markgraf DF; Burkart V; Müssig K; Hwang JH; Asplund O; Groop L; Ahlqvist E; Seissler J; Nawroth P; Kopf S; Schmid SM; Stumvoll M; Pfeiffer AFH; Kabisch S; Tselmin S; Häring HU; Ziegler D; Kuss O; Szendroedi J; Roden M;
    Lancet Diabetes Endocrinol; 2019 Sep; 7(9):684-694. PubMed ID: 31345776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are the Different Diabetes Subgroups Correlated With All-Cause, Cancer-Related, and Cardiovascular-Related Mortality?
    Li PF; Chen WL
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32893854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study.
    Slieker RC; Donnelly LA; Fitipaldi H; Bouland GA; Giordano GN; Åkerlund M; Gerl MJ; Ahlqvist E; Ali A; Dragan I; Festa A; Hansen MK; Mansour Aly D; Kim M; Kuznetsov D; Mehl F; Klose C; Simons K; Pavo I; Pullen TJ; Suvitaival T; Wretlind A; Rossing P; Lyssenko V; Legido-Quigley C; Groop L; Thorens B; Franks PW; Ibberson M; Rutter GA; Beulens JWJ; 't Hart LM; Pearson ER
    Diabetologia; 2021 Sep; 64(9):1982-1989. PubMed ID: 34110439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study.
    Raverdy V; Cohen RV; Caiazzo R; Verkindt H; Petry TBZ; Marciniak C; Legendre B; Bauvin P; Chatelain E; Duhamel A; Drumez E; Oukhouya-Daoud N; Chetboun M; Baud G; Ahlqvist E; Wierup N; Asplund O; Laferrère B; Groop L; Pattou F
    Lancet Diabetes Endocrinol; 2022 Mar; 10(3):167-176. PubMed ID: 35148818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of plasma leptin and resistin in novel subgroups of type 2 diabetes driven by cluster analysis.
    Peng X; Huang J; Zou H; Peng B; Xia S; Dong K; Sun N; Tao J; Yang Y
    Lipids Health Dis; 2022 Jan; 21(1):7. PubMed ID: 34996484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes.
    Maalmi H; Herder C; Bönhof GJ; Strassburger K; Zaharia OP; Rathmann W; Burkart V; Szendroedi J; Roden M; Ziegler D;
    Diabetologia; 2022 Mar; 65(3):552-562. PubMed ID: 34800144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study.
    Anjana RM; Baskar V; Nair ATN; Jebarani S; Siddiqui MK; Pradeepa R; Unnikrishnan R; Palmer C; Pearson E; Mohan V
    BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32816869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Swedish Diabetes Re-Grouping Scheme in Adult-Onset Diabetes in China.
    Li X; Yang S; Cao C; Yan X; Zheng L; Zheng L; Da J; Tang X; Ji L; Yang X; Zhou Z
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32808015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to insulin glargine 100 U/mL treatment in newly-defined subgroups of type 2 diabetes: Post hoc pooled analysis of insulin-naïve participants from nine randomised clinical trials.
    Landgraf W; Bigot G; Frier BM; Bolli GB; Owens DR
    Prim Care Diabetes; 2023 Aug; 17(4):379-385. PubMed ID: 37142540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of canagliflozin in diabetes subgroups stratified by data-driven clustering or a supervised machine learning method: a post hoc analysis of canagliflozin clinical trial data.
    Zou X; Huang Q; Luo Y; Ren Q; Han X; Zhou X; Ji L
    Diabetologia; 2022 Sep; 65(9):1424-1435. PubMed ID: 35802168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics of Inpatients With New-Onset Diabetes Mellitus in Eastern China: Based on Novel Clustering Analysis.
    Song X; Lv Y; Huang N; Sun J; Yang T; Wang X; Zhang J; Zhou Z; Gao H; Li J; Zhang W; Yin H; Wei Q; Wang K; Li L
    Front Endocrinol (Lausanne); 2022; 13():927661. PubMed ID: 35966053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes duration and types of diabetes treatment in data-driven clusters of patients with diabetes.
    Zhang J; Deng Y; Wan Y; Wang J; Xu J
    Front Endocrinol (Lausanne); 2022; 13():994836. PubMed ID: 36457559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clustering and phenotyping approaches for subclassification of type 2 diabetes and its association with remission in Indian population.
    Tripathi P; Vyawahare A; Kadam N; Tiwari D; Biswas MD; Kathrikolly T; Sharma B; Vijayakumar V; Kuppusamy M
    Sci Rep; 2024 Aug; 14(1):20260. PubMed ID: 39217248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial.
    Landgraf W; Owens DR; Frier BM; Bolli GB
    Diabetes Obes Metab; 2024 Feb; 26(2):503-511. PubMed ID: 37860918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes subgroups and sociodemographic inequalities in Mexico: a cross-sectional analysis of nationally representative surveys from 2016 to 2022.
    Antonio-Villa NE; Bello-Chavolla OY; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Basile-Alvarez MR; Núñez-Luna A; Sánchez-Castro P; Fernández-Chirino L; Díaz-Sánchez JP; Dávila-López G; Posadas-Sánchez R; Vargas-Alarcón G; Caballero AE; Florez JC; Seiglie JA
    Lancet Reg Health Am; 2024 May; 33():100732. PubMed ID: 38616917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiorenal Risk Profiles Among Data-Driven Type 2 Diabetes Sub-Phenotypes: A
    Gao H; Wang K; Zhao W; Zhuang J; Jiang Y; Zhang L; Liu Q; Ahmadizar F
    Front Endocrinol (Lausanne); 2022; 13():828403. PubMed ID: 35464070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtypes of type 2 diabetes and their association with outcomes in Korean adults - A cluster analysis of community-based prospective cohort.
    Hwang YC; Ahn HY; Jun JE; Jeong IK; Ahn KJ; Chung HY
    Metabolism; 2023 Apr; 141():155514. PubMed ID: 36746321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes classification: a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort.
    Christensen DH; Nicolaisen SK; Ahlqvist E; Stidsen JV; Nielsen JS; Hojlund K; Olsen MH; García-Calzón S; Ling C; Rungby J; Brandslund I; Vestergaard P; Jessen N; Hansen T; Brøns C; Beck-Nielsen H; Sørensen HT; Thomsen RW; Vaag A
    BMJ Open Diabetes Res Care; 2022 Apr; 10(2):. PubMed ID: 35428673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.